BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15653309)

  • 21. A recessive major gene controls the mitsuda reaction in a region endemic for leprosy.
    Ranque B; Alcais A; Thuc NV; Woynard S; Thai VH; Huong NT; Ba NN; Khoa PX; Schurr E; Abel L
    J Infect Dis; 2005 Oct; 192(8):1475-82. PubMed ID: 16170767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FoxP3 provides competitive fitness to CD4⁺CD25⁺ T cells in leprosy patients via transcriptional regulation.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Eur J Immunol; 2014 Feb; 44(2):431-9. PubMed ID: 24214631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leprosy as a model of immunity.
    Degang Y; Nakamura K; Akama T; Ishido Y; Luo Y; Ishii N; Suzuki K
    Future Microbiol; 2014; 9(1):43-54. PubMed ID: 24328380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leprosy as a genetic disease.
    Alter A; Grant A; Abel L; Alcaïs A; Schurr E
    Mamm Genome; 2011 Feb; 22(1-2):19-31. PubMed ID: 20936290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative analyses of leprosy susceptibility genes indicate a common autoimmune profile.
    Zhang DF; Wang D; Li YY; Yao YG
    J Dermatol Sci; 2016 Apr; 82(1):18-27. PubMed ID: 26805555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cell fate regulator NUPR1 is induced by Mycobacterium leprae via type I interferon in human leprosy.
    R Andrade P; Mehta M; Lu J; M B Teles R; Montoya D; O Scumpia P; Nunes Sarno E; Ochoa MT; Ma F; Pellegrini M; Modlin RL
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007589. PubMed ID: 31344041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association study of the single nucleotide polymorphisms of PARK2 and PACRG with leprosy susceptibility in Chinese population.
    Li J; Liu H; Liu J; Fu X; Yu Y; Yu G; Chen S; Chu T; Lu N; Bao F; Yuan C; Zhang F
    Eur J Hum Genet; 2012 May; 20(5):488-9. PubMed ID: 22009144
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naive armadillos.
    Pena M; Geluk A; Van Der Ploeg-Van Schip JJ; Franken KL; Sharma R; Truman R
    Lepr Rev; 2011 Dec; 82(4):422-31. PubMed ID: 22439281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-linked genetic control of host response to Mycobacterium leprae.
    de Vries RR; Fat RF; Nijenhuis LE; van Rood JJ
    Lancet; 1976 Dec; 2(7999):1328-30. PubMed ID: 63804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological implications of Mycobacterium leprae gene expression during infection.
    Williams DL; Torrero M; Wheeler PR; Truman RW; Yoder M; Morrison N; Bishai WR; Gillis TP
    J Mol Microbiol Biotechnol; 2004; 8(1):58-72. PubMed ID: 15741741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of leprosy: expected and unexpected developments and perspectives.
    Sauer ME; Salomão H; Ramos GB; D'Espindula HR; Rodrigues RS; Macedo WC; Sindeaux RH; Mira MT
    Clin Dermatol; 2015; 33(1):99-107. PubMed ID: 25432815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
    Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
    Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights from animal models on the immunogenetics of leprosy: a review.
    Adams LB; Pena MT; Sharma R; Hagge DA; Schurr E; Truman RW
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():197-208. PubMed ID: 23283472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response.
    Ferreira FR; Goulart LR; Silva HD; Goulart IM
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):457-67. PubMed ID: 15755200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population.
    Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers for leprosy: would you prefer T (cells)?
    Geluk A
    Lepr Rev; 2013 Mar; 84(1):3-12. PubMed ID: 23741878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a mouse food pad model for detection of sub clinical leprosy.
    Lahiri R; Randhawa B; Franken KL; Duthie MS; Spencer JS; Geluk A; Krahenbuhl JL
    Lepr Rev; 2011 Dec; 82(4):432-44. PubMed ID: 22439282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postgenomic Mycobacterium leprae antigens for cellular and serological diagnosis of M. leprae exposure, infection and leprosy disease.
    Geluk A; Duthie MS; Spencer JS
    Lepr Rev; 2011 Dec; 82(4):402-21. PubMed ID: 22439280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.